The “obesity = dangerous” message is everywhere. Headline-making studies underscore the link between excess fat and more than 200 chronic diseases , and ads for the new wave of weight-loss agents— GLP-1 receptor agonist drugs —flood social media. This idea is particularly embedded in discussions of metabolic health, as obesity increases the likelihood of insulin resistance, prediabetes, and metabolic syndrome , a cluster of conditions that elevate diabetes, stroke, and cardiovascular disease…